HR 6321 · 119th Congress

Lung Cancer Medicare Access to Precise Testing Act

This bill makes Medicare cover the cost of special genetic and molecular tests for people diagnosed with lung cancer. Right now, Medicare doesn't automatically pay for these biomarker tests, which identify specific genetic mutations, proteins, or other biological markers in a patient's cancer cells. These tests help…

Sponsor

Gottheimer, Josh (D-New Jersey)

Introduced

2025-11-28

Policy area

Health

Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.